Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation

Lenalidomide is a potent anti-myeloma drug with immunomodulatory properties. It is increasingly used in a low-dose maintenance setting to prolong remission duration after standard treatment. Data on the in vivo effects of lenalidomide are scarce and sometimes different from the well-described in vit...

Descripción completa

Detalles Bibliográficos
Autores principales: Fostier, Karel, Caers, Jo, Meuleman, Nathalie, Broos, Katrijn, Corthals, Jurgen, Thielemans, Kris, Schots, Rik, De Keersmaecker, Brenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945510/
https://www.ncbi.nlm.nih.gov/pubmed/29755666
http://dx.doi.org/10.18632/oncotarget.24944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945510/
https://www.ncbi.nlm.nih.gov/pubmed/29755666
http://dx.doi.org/10.18632/oncotarget.24944

Ejemplares similares